Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Medical News
  3. Ophthalmology

Prolonged Eye Patching Does Not Have Negative Impact on Family Stress Levels or Child’s Development According to First of Its Kind Study

ReachMD Healthcare Image
04/23/2024
News Faviconpublichealth.gmu.edu

Professor Carolyn Drews-Botsch and her team examined whether extended periods of patching for children with unilateral congenital cataracts (UCC) negatively impacted parenting stress, child’s motor development, child behavior, or child’s self-perception. 

Parents of children with unilateral congenital cataracts (UCC) may wonder how long to patch and if extended periods of patching might impact their child’s development or cause undue stress for the child or family, particularly among children with poor vision in the treated eye. A first-of-its-kind study found that families whose children have UCC can rest easier knowing that continuing to patch throughout the preschool years, does not negatively impact parenting stress or child development, motor functioning, and self-perception when compared to children for whom patching was abandoned. 

To the authors’ knowledge, this is the first study to look at the possible negative impact of patching on child and family functioning that focuses on children with UCC or that focuses on children with poor vision in the affected eye. 

“Our results are important for the group of children who are born with a unilateral congenital cataract. Patching is prescribed for these children for half of their waking hours throughout the first 5-6 years of life. Thus, many families and health care providers wonder whether they are hurting these children by asking them to continue patching – in the hopes of improving their vision, even when they do not see well in the treated eye,” said Drews-Botsch, principal investigator and chair of Mason’s Department of Global and Community Health. “These results do not support changes to the current practice guidelines of patching children. Parents may be reassured that continuing to patch is not likely to cause significant harm to families or children.” 

Children with unilateral congenital cataracts (UCC) are born with cloudy or opaque vision in one eye that, if left untreated, can result in blindness in that eye. The condition is treated, as it is in adults, with surgery. After the surgery, occlusion therapy is prescribed to avoid lazy eye (deprivation amblyopia). Also known as patching, occlusion therapy is when the child wears a patch covering the eye that did not have the cataract and it is needed to  allow vision in the affected eye. However, even with the best treatment, about half of these children will remain legally blind in the treated eye. 

Parenting stress, child behavior problems, motor functioning, and child self-perception were similar for all levels of patching, including children who wore patches fewer than 15 minutes a day and those who were reported to be patched at least 2 hours a day. The study compared children with UCC with poor vision in the affected eye whose parents continued patching throughout the first 5 years of age to children with UCC whose parents discontinued patching at some point during the first 4 years of age.  

These results were somewhat surprising since, anecdotally, patching is believed to cause the family stress because it can be difficult for parents to get children to wear the patch consistently for the required amount of time and while patched, the children are severely visually impaired, possibly impairing development of other skills. 

The study was funded by a National Institutes of Health R21 grant. This cohort study was conducted in 2023 using data collected between 2006 and 2016 in the Infact Aphakia Treatment Study, which included participants with a vision of 20/2000 (visual acuity) or worse. 

"Patching in Children with Unilateral Congenital Cataract and Child Functioning and Child Stress” was published online in April 2024 in JAMA Ophthalmology. Co-authors on the paper include Scott Lambert from Stanford University, Marianne Celano and George Cotsonis from Emory University, and Genie Hartmann from Akron Children’s Hospital, and Assistant Professor in Mason’s Department of Global and Community Health Jaffer Zaidi

Schedule23 Nov 2024